The Future of Pharmaceutical Psychedelics in Mental Health Treatment

In this episode we speak with Erica Siegal, a licensed clinical social worker, professional harm reductionist community organizer, psychedelic-assisted psychotherapist, and founder of NEST Harm Reduction Consulting in California. She worked as a psychotherapist researcher on the phase two and phase three FDA approved MDMA assisted psychotherapy clinical trials from 2014 to 2019. 

Join us as we discuss: 

• Emerging findings about psychedelic treatments for individuals with mental health issues 
• The pace of psychedelic substance regulation on a state and federal level  
• Psychedelic substance interventions in the case of opioid addiction treatments

Views expressed in this material are opinions of the host and the guest, and do not necessarily reflect the views of Rigaku Analytical Devices.

Listen and subscribe on your favorite podcast player:

Apple Podcasts

Spotify

To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player here: https://plinkhq.com/i/1625927161?to=page